Calcifediol: Mechanisms of Action.
Level 5 - mechanism / opinion, no new human data
Narrative review describing biological mechanisms without primary human data or systematic methodology.
PubMed 37892484 · doi:10.3390/nu15204409
What was done
This narrative review synthesizes the molecular mechanisms of action of calcifediol (25-hydroxyvitamin D) and calcitriol, focusing on genomic signaling via the vitamin D receptor (VDR) and vitamin D-responsive elements (VDREs), as well as rapid non-genomic pathways involving membrane-associated VDR (mVDR) and protein disulfide isomerase family A member 3 (Pdia3).
What was found
The abstract reports no quantitative values or statistical findings. It outlines that calcifediol directly binds the intracellular VDR (with lower affinity than calcitriol) to regulate gene transcription, and interacts with membrane-bound receptors such as mVDR and Pdia3 to trigger rapid, non-transcriptional signaling cascades.
Why it matters
Demonstrating direct genomic and non-genomic activity of calcifediol reframes it from a passive precursor to an active metabolite, informing potential therapeutic strategies for vitamin D deficiency-related conditions.
Limits
As a narrative review, it presents no original experimental or clinical human data, reports no quantitative binding or affinity metrics in the abstract, and lacks a systematic search protocol.
Cited by
- supports Vitamin D has a steroid structure similar to cortisol, testosterone, estrogen, and progesterone, allowing it to enter the cell nucleus and regulate gene transcription.